BH13 Current Wig Prescribing Practices and Financial Evaluation in a National Health Service Foundation Trust: Lessons Learned and Future Challenges

The study examines wig prescribing practices and financial implications within a National Health Service (NHS) foundation trust, highlighting the essential role of wigs in managing alopecia due to limited treatment options. Over 12 months, 324 prescriptions were issued to 200 patients, predominantly female, with a median age of 52. Nonscarring alopecia accounted for 57.7% of cases, and 60.5% of wigs prescribed were acrylic. The study found significant regional discrepancies in wig funding, with 69.1% of prescriptions for out-of-area patients. The hospital's annual wig cost was £193,403. Psychological assessments showed wigs positively impact patients' wellbeing. The study underscores the need for equitable NHS wig provision and supports ongoing reviews to address these challenges.